Optival Health Solutions, a subsidiary of MedPlus Health Services, has received two temporary drug license suspension orders for individual store locations in Andhra Pradesh and Telangana. The closures, effective April 2026, result in a total estimated revenue loss of Rs 1.25 lacs. Operations at these specific sites are impacted for durations of seven days and two days, respectively, due to alleged contraventions under existing industry health and safety regulations.
Details of Store Suspensions
MedPlus Health Services Limited has confirmed that its subsidiary, Optival Health Solutions Private Limited, has been issued two separate suspension orders regarding drug licenses. The orders affect one retail location in Andhra Pradesh and one in Telangana, both of which received directives dated April 19, 2026.
Financial and Operational Impact
The suspensions have specific durations based on the location. The store at Kodumur New Bus Stand in Andhra Pradesh is subject to a seven-day suspension, resulting in a projected revenue impact of Rs 0.88 lacs. Simultaneously, the store on Miryalaguda Road in Telangana faces a two-day suspension, with an estimated revenue loss of Rs 0.37 lacs.
Regulatory Compliance
These actions were initiated by local drug control authorities citing alleged violations of the Drugs and Cosmetics Act, 1940 and associated rules. The company maintains its commitment to transparency regarding these operational interruptions and notes that the combined financial impact on its broader operations remains minimal.
Source: BSE
